1. Volume 84, Issue 2, Pages 353-358 (August 2013)
Decline in 20-year mortality after myocardial infarction in patients with chronic kidney disease: evolution from the prethrombolysis to the percutaneous coronary intervention era 
Sjoerd T. Nauta, Ron T. van Domburg, Rutger-Jan Nuis, Martijn Akkerhuis, Jaap W. Deckers 
Kidney International 
Volume 84, Issue 2, Pages (August 2013)
DOI: /ki
Copyright © 2013 International Society of Nephrology Terms and Conditions

2. Figure 1
Distribution of study population according to renal function and study period.
Kidney International  , DOI: ( /ki )
Copyright © 2013 International Society of Nephrology Terms and Conditions

3. Figure 2
Treatment of patients over time. (a) Use of reperfusion therapy in ST-segment elevation myocardial infarction. (b, c) Use of evidence-based medical care in myocardial infarction patients. ACE, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; ASA, aspirin; ICCU, intensive coronary care unit; PCI, percutaneous coronary intervention; ThT, thrombolytic therapy. Cochran statistic with correction for calendar period was used to calculate P-values between normal renal function and stage 4–5 chronic kidney disease.
Kidney International  , DOI: ( /ki )
Copyright © 2013 International Society of Nephrology Terms and Conditions

4. Figure 3 Kaplan–Meier curves of mortality according to renal function.
Kidney International  , DOI: ( /ki )
Copyright © 2013 International Society of Nephrology Terms and Conditions